On June 7, the Food and Drug Administration (FDA) approved the first new Alzheimer’s medication in 18 years. Significantly, it is the first approved treatment that’s designed to address the actual disease process and not just dementia symptoms. But aducanumab, which goes by the brand name Aduhelm, has sparked controversy among medical experts; both Republican and Democratic […]

Lori McKenna, LICSW, social worker with the UVM Medical Center’s Memory Program answers questions about caring for a loved one with Alzheimer’s disease. What challenges face the caregiver of a person with dementia? Lori McKenna: The unknown regarding the progression of the disease. The grief that they may experience following diagnosis: anger, fear, depression, isolation, […]

Diabetic retinopathy is a disease that affects nearly 8 million Americans and is a leading cause of blindness in adults. In the latest episode of HealthSource Radio, Dr. Christopher Brady talks about the disease. Brady is an ophthalmologist at the UVM Medical Center and assistant professor at the Larner College of Medicine at UVM. Listen to […]

Recently, the World Health Organization released its first-ever guidelines for reducing risk for dementia and cognitive decline. Today, dementia is a global-health priority. The Centers for Disease Control and Prevention predict that the U.S. burden of Alzheimer’s disease and related dementias will double by 2060 to 13.9 million people. The guidelines seek to help people […]